nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—Jaundice—Pentoxifylline—systemic scleroderma	0.00684	0.00684	CcSEcCtD
Propericiazine—Asthma—Mometasone—systemic scleroderma	0.00679	0.00679	CcSEcCtD
Propericiazine—Ventricular tachycardia—Lisinopril—systemic scleroderma	0.00673	0.00673	CcSEcCtD
Propericiazine—Pulmonary embolism—Lisinopril—systemic scleroderma	0.00673	0.00673	CcSEcCtD
Propericiazine—Amenorrhoea—Mycophenolate mofetil—systemic scleroderma	0.00671	0.00671	CcSEcCtD
Propericiazine—Jaundice cholestatic—Mycophenolate mofetil—systemic scleroderma	0.00671	0.00671	CcSEcCtD
Propericiazine—Sudden death—Methotrexate—systemic scleroderma	0.00653	0.00653	CcSEcCtD
Propericiazine—Eosinophilia—Captopril—systemic scleroderma	0.00591	0.00591	CcSEcCtD
Propericiazine—Pulmonary embolism—Mycophenolate mofetil—systemic scleroderma	0.0059	0.0059	CcSEcCtD
Propericiazine—Ventricular tachycardia—Mycophenolate mofetil—systemic scleroderma	0.0059	0.0059	CcSEcCtD
Propericiazine—Arrhythmia—Pentoxifylline—systemic scleroderma	0.00563	0.00563	CcSEcCtD
Propericiazine—Photosensitivity—Lisinopril—systemic scleroderma	0.00557	0.00557	CcSEcCtD
Propericiazine—Erectile dysfunction—Captopril—systemic scleroderma	0.00549	0.00549	CcSEcCtD
Propericiazine—Deep vein thrombosis—Methotrexate—systemic scleroderma	0.00549	0.00549	CcSEcCtD
Propericiazine—Photosensitivity reaction—Captopril—systemic scleroderma	0.00545	0.00545	CcSEcCtD
Propericiazine—Nasal congestion—Lisinopril—systemic scleroderma	0.00537	0.00537	CcSEcCtD
Propericiazine—Glaucoma—Prednisone—systemic scleroderma	0.00531	0.00531	CcSEcCtD
Propericiazine—Gynaecomastia—Mycophenolate mofetil—systemic scleroderma	0.00528	0.00528	CcSEcCtD
Propericiazine—Jaundice—Captopril—systemic scleroderma	0.00518	0.00518	CcSEcCtD
Propericiazine—Hypokalaemia—Leflunomide—systemic scleroderma	0.00518	0.00518	CcSEcCtD
Propericiazine—Vision blurred—Pentoxifylline—systemic scleroderma	0.00517	0.00517	CcSEcCtD
Propericiazine—Tremor—Pentoxifylline—systemic scleroderma	0.00514	0.00514	CcSEcCtD
Propericiazine—Agitation—Pentoxifylline—systemic scleroderma	0.00504	0.00504	CcSEcCtD
Propericiazine—Angioedema—Pentoxifylline—systemic scleroderma	0.00501	0.00501	CcSEcCtD
Propericiazine—Agranulocytosis—Captopril—systemic scleroderma	0.00496	0.00496	CcSEcCtD
Propericiazine—Hypokalaemia—Mycophenolic acid—systemic scleroderma	0.00494	0.00494	CcSEcCtD
Propericiazine—Asthma—Leflunomide—systemic scleroderma	0.00492	0.00492	CcSEcCtD
Propericiazine—Eosinophilia—Leflunomide—systemic scleroderma	0.00487	0.00487	CcSEcCtD
Propericiazine—Sweating increased—Leflunomide—systemic scleroderma	0.00479	0.00479	CcSEcCtD
Propericiazine—Asthma—Mycophenolic acid—systemic scleroderma	0.00469	0.00469	CcSEcCtD
Propericiazine—Pneumonia—Azathioprine—systemic scleroderma	0.00467	0.00467	CcSEcCtD
Propericiazine—Dry mouth—Pentoxifylline—systemic scleroderma	0.00457	0.00457	CcSEcCtD
Propericiazine—Amenorrhoea—Prednisone—systemic scleroderma	0.00455	0.00455	CcSEcCtD
Propericiazine—Confusional state—Pentoxifylline—systemic scleroderma	0.00451	0.00451	CcSEcCtD
Propericiazine—Oedema—Pentoxifylline—systemic scleroderma	0.00448	0.00448	CcSEcCtD
Propericiazine—Infection—Pentoxifylline—systemic scleroderma	0.00445	0.00445	CcSEcCtD
Propericiazine—Hyperglycaemia—Leflunomide—systemic scleroderma	0.00444	0.00444	CcSEcCtD
Propericiazine—Pneumonia—Leflunomide—systemic scleroderma	0.00441	0.00441	CcSEcCtD
Propericiazine—Tachycardia—Pentoxifylline—systemic scleroderma	0.00437	0.00437	CcSEcCtD
Propericiazine—Agranulocytosis—Azathioprine—systemic scleroderma	0.00433	0.00433	CcSEcCtD
Propericiazine—Hyperhidrosis—Pentoxifylline—systemic scleroderma	0.00433	0.00433	CcSEcCtD
Propericiazine—Angioedema—Mometasone—systemic scleroderma	0.00432	0.00432	CcSEcCtD
Propericiazine—Erectile dysfunction—Mycophenolic acid—systemic scleroderma	0.00432	0.00432	CcSEcCtD
Propericiazine—Jaundice—Leflunomide—systemic scleroderma	0.00427	0.00427	CcSEcCtD
Propericiazine—Weight increased—Mycophenolic acid—systemic scleroderma	0.00427	0.00427	CcSEcCtD
Propericiazine—Hyperglycaemia—Mycophenolic acid—systemic scleroderma	0.00423	0.00423	CcSEcCtD
Propericiazine—Asthma—Lisinopril—systemic scleroderma	0.00422	0.00422	CcSEcCtD
Propericiazine—Pneumonia—Mycophenolic acid—systemic scleroderma	0.00421	0.00421	CcSEcCtD
Propericiazine—Eosinophilia—Lisinopril—systemic scleroderma	0.00418	0.00418	CcSEcCtD
Propericiazine—Hypotension—Pentoxifylline—systemic scleroderma	0.00418	0.00418	CcSEcCtD
Propericiazine—Sweating increased—Lisinopril—systemic scleroderma	0.00412	0.00412	CcSEcCtD
Propericiazine—Agranulocytosis—Leflunomide—systemic scleroderma	0.00409	0.00409	CcSEcCtD
Propericiazine—Jaundice—Mycophenolic acid—systemic scleroderma	0.00408	0.00408	CcSEcCtD
Propericiazine—Insomnia—Pentoxifylline—systemic scleroderma	0.00405	0.00405	CcSEcCtD
Propericiazine—Dyspnoea—Pentoxifylline—systemic scleroderma	0.00399	0.00399	CcSEcCtD
Propericiazine—Somnolence—Pentoxifylline—systemic scleroderma	0.00398	0.00398	CcSEcCtD
Propericiazine—Dry mouth—Mometasone—systemic scleroderma	0.00394	0.00394	CcSEcCtD
Propericiazine—Vision blurred—Captopril—systemic scleroderma	0.00392	0.00392	CcSEcCtD
Propericiazine—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.0039	0.0039	CcSEcCtD
Propericiazine—Hypokalaemia—Mycophenolate mofetil—systemic scleroderma	0.0039	0.0039	CcSEcCtD
Propericiazine—Erectile dysfunction—Lisinopril—systemic scleroderma	0.00389	0.00389	CcSEcCtD
Propericiazine—Photosensitivity reaction—Lisinopril—systemic scleroderma	0.00386	0.00386	CcSEcCtD
Propericiazine—Weight increased—Lisinopril—systemic scleroderma	0.00384	0.00384	CcSEcCtD
Propericiazine—Infection—Mometasone—systemic scleroderma	0.00384	0.00384	CcSEcCtD
Propericiazine—Constipation—Pentoxifylline—systemic scleroderma	0.00383	0.00383	CcSEcCtD
Propericiazine—Hyperglycaemia—Lisinopril—systemic scleroderma	0.00381	0.00381	CcSEcCtD
Propericiazine—Angioedema—Captopril—systemic scleroderma	0.0038	0.0038	CcSEcCtD
Propericiazine—Pneumonia—Lisinopril—systemic scleroderma	0.00379	0.00379	CcSEcCtD
Propericiazine—Arrhythmia—Azathioprine—systemic scleroderma	0.00372	0.00372	CcSEcCtD
Propericiazine—Asthma—Mycophenolate mofetil—systemic scleroderma	0.0037	0.0037	CcSEcCtD
Propericiazine—Jaundice—Lisinopril—systemic scleroderma	0.00367	0.00367	CcSEcCtD
Propericiazine—Cardiac disorder—Leflunomide—systemic scleroderma	0.00365	0.00365	CcSEcCtD
Propericiazine—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00354	0.00354	CcSEcCtD
Propericiazine—Arrhythmia—Leflunomide—systemic scleroderma	0.00352	0.00352	CcSEcCtD
Propericiazine—Agranulocytosis—Lisinopril—systemic scleroderma	0.00352	0.00352	CcSEcCtD
Propericiazine—Cardiac disorder—Mycophenolic acid—systemic scleroderma	0.00348	0.00348	CcSEcCtD
Propericiazine—Dry mouth—Captopril—systemic scleroderma	0.00346	0.00346	CcSEcCtD
Propericiazine—Dyspnoea—Mometasone—systemic scleroderma	0.00344	0.00344	CcSEcCtD
Propericiazine—Confusional state—Captopril—systemic scleroderma	0.00342	0.00342	CcSEcCtD
Propericiazine—Erectile dysfunction—Mycophenolate mofetil—systemic scleroderma	0.00341	0.00341	CcSEcCtD
Propericiazine—Weight increased—Mycophenolate mofetil—systemic scleroderma	0.00337	0.00337	CcSEcCtD
Propericiazine—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.00335	0.00335	CcSEcCtD
Propericiazine—Pulmonary embolism—Methotrexate—systemic scleroderma	0.00334	0.00334	CcSEcCtD
Propericiazine—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.00334	0.00334	CcSEcCtD
Propericiazine—Pneumonia—Mycophenolate mofetil—systemic scleroderma	0.00332	0.00332	CcSEcCtD
Propericiazine—Tachycardia—Captopril—systemic scleroderma	0.00331	0.00331	CcSEcCtD
Propericiazine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.0033	0.0033	CcSEcCtD
Propericiazine—Vision blurred—Leflunomide—systemic scleroderma	0.00323	0.00323	CcSEcCtD
Propericiazine—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00322	0.00322	CcSEcCtD
Propericiazine—Hypotension—Captopril—systemic scleroderma	0.00317	0.00317	CcSEcCtD
Propericiazine—Angioedema—Leflunomide—systemic scleroderma	0.00313	0.00313	CcSEcCtD
Propericiazine—Increased appetite—Prednisone—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Propericiazine—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00308	0.00308	CcSEcCtD
Propericiazine—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00308	0.00308	CcSEcCtD
Propericiazine—Insomnia—Captopril—systemic scleroderma	0.00307	0.00307	CcSEcCtD
Propericiazine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00306	0.00306	CcSEcCtD
Propericiazine—Tremor—Mycophenolic acid—systemic scleroderma	0.00306	0.00306	CcSEcCtD
Propericiazine—Body temperature increased—Mometasone—systemic scleroderma	0.00305	0.00305	CcSEcCtD
Propericiazine—Dyspnoea—Captopril—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Propericiazine—Arrhythmia—Lisinopril—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Propericiazine—Somnolence—Captopril—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Propericiazine—Agitation—Mycophenolic acid—systemic scleroderma	0.003	0.003	CcSEcCtD
Propericiazine—Gynaecomastia—Methotrexate—systemic scleroderma	0.00299	0.00299	CcSEcCtD
Propericiazine—Infection—Azathioprine—systemic scleroderma	0.00294	0.00294	CcSEcCtD
Propericiazine—Constipation—Captopril—systemic scleroderma	0.0029	0.0029	CcSEcCtD
Propericiazine—Dry mouth—Leflunomide—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Propericiazine—Vomiting—Pentoxifylline—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Propericiazine—Rash—Pentoxifylline—systemic scleroderma	0.00282	0.00282	CcSEcCtD
Propericiazine—Dermatitis—Pentoxifylline—systemic scleroderma	0.00282	0.00282	CcSEcCtD
Propericiazine—Infection—Leflunomide—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Propericiazine—Vision blurred—Lisinopril—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Propericiazine—Hypotension—Azathioprine—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Propericiazine—Photosensitivity—Methotrexate—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Propericiazine—Tremor—Lisinopril—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Propericiazine—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00275	0.00275	CcSEcCtD
Propericiazine—Tachycardia—Leflunomide—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Propericiazine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Propericiazine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.0027	0.0027	CcSEcCtD
Propericiazine—Angioedema—Lisinopril—systemic scleroderma	0.00269	0.00269	CcSEcCtD
Propericiazine—Confusional state—Mycophenolic acid—systemic scleroderma	0.00269	0.00269	CcSEcCtD
Propericiazine—Body temperature increased—Captopril—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Propericiazine—Oedema—Mycophenolic acid—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Propericiazine—Nausea—Pentoxifylline—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Propericiazine—Infection—Mycophenolic acid—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Propericiazine—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Propericiazine—Diarrhoea—Mometasone—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Propericiazine—Hypokalaemia—Prednisone—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Propericiazine—Hypotension—Leflunomide—systemic scleroderma	0.00261	0.00261	CcSEcCtD
Propericiazine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.0026	0.0026	CcSEcCtD
Propericiazine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Propericiazine—Insomnia—Leflunomide—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Propericiazine—Dyspnoea—Leflunomide—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Propericiazine—Hypotension—Mycophenolic acid—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Propericiazine—Vomiting—Mometasone—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Propericiazine—Dry mouth—Lisinopril—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Propericiazine—Sweating increased—Prednisone—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Propericiazine—Rash—Mometasone—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Propericiazine—Dermatitis—Mometasone—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Propericiazine—Confusional state—Lisinopril—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Propericiazine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Propericiazine—Insomnia—Mycophenolic acid—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Propericiazine—Oedema—Lisinopril—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Propericiazine—Constipation—Leflunomide—systemic scleroderma	0.00239	0.00239	CcSEcCtD
Propericiazine—Infection—Lisinopril—systemic scleroderma	0.00239	0.00239	CcSEcCtD
Propericiazine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Propericiazine—Somnolence—Mycophenolic acid—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Propericiazine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Propericiazine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Propericiazine—Tachycardia—Lisinopril—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Propericiazine—Body temperature increased—Azathioprine—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Propericiazine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00232	0.00232	CcSEcCtD
Propericiazine—Diarrhoea—Captopril—systemic scleroderma	0.00232	0.00232	CcSEcCtD
Propericiazine—Erectile dysfunction—Prednisone—systemic scleroderma	0.00231	0.00231	CcSEcCtD
Propericiazine—Nausea—Mometasone—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Propericiazine—Weight increased—Prednisone—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Propericiazine—Constipation—Mycophenolic acid—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Propericiazine—Hyperglycaemia—Prednisone—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Propericiazine—Hypotension—Lisinopril—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Propericiazine—Body temperature increased—Leflunomide—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Propericiazine—Hypersensitivity—Azathioprine—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Propericiazine—Insomnia—Lisinopril—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Propericiazine—Vomiting—Captopril—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Propericiazine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Propericiazine—Dyspnoea—Lisinopril—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Propericiazine—Rash—Captopril—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Propericiazine—Dermatitis—Captopril—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Propericiazine—Somnolence—Lisinopril—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Propericiazine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Propericiazine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Propericiazine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Propericiazine—Asthma—Methotrexate—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Propericiazine—Infection—Mycophenolate mofetil—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Propericiazine—Eosinophilia—Methotrexate—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Propericiazine—Hypersensitivity—Leflunomide—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Propericiazine—Constipation—Lisinopril—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Propericiazine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Propericiazine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Propericiazine—Diarrhoea—Azathioprine—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Propericiazine—Nausea—Captopril—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Propericiazine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Propericiazine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Propericiazine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Propericiazine—Diarrhoea—Leflunomide—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Propericiazine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Propericiazine—Body temperature increased—Lisinopril—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Propericiazine—Vomiting—Azathioprine—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Propericiazine—Pneumonia—Methotrexate—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Propericiazine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Propericiazine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Propericiazine—Drowsiness—Methotrexate—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Propericiazine—Rash—Azathioprine—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Propericiazine—Dermatitis—Azathioprine—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Propericiazine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Propericiazine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Propericiazine—Arrhythmia—Prednisone—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Propericiazine—Vomiting—Leflunomide—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Propericiazine—Hypersensitivity—Lisinopril—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Propericiazine—Rash—Leflunomide—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Propericiazine—Dermatitis—Leflunomide—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Propericiazine—Nausea—Azathioprine—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Propericiazine—Agranulocytosis—Methotrexate—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Propericiazine—Vomiting—Mycophenolic acid—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Propericiazine—Rash—Mycophenolic acid—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Propericiazine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Propericiazine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Propericiazine—Nausea—Leflunomide—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Propericiazine—Vision blurred—Prednisone—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Propericiazine—Diarrhoea—Lisinopril—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Propericiazine—Agitation—Prednisone—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Propericiazine—Angioedema—Prednisone—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Propericiazine—Nausea—Mycophenolic acid—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Propericiazine—Cardiac disorder—Methotrexate—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Propericiazine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Propericiazine—Vomiting—Lisinopril—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Propericiazine—Rash—Lisinopril—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Propericiazine—Dermatitis—Lisinopril—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Propericiazine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Propericiazine—Nausea—Lisinopril—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Propericiazine—Oedema—Prednisone—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Propericiazine—Infection—Prednisone—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Propericiazine—Tachycardia—Prednisone—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Propericiazine—Hyperhidrosis—Prednisone—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Propericiazine—Vision blurred—Methotrexate—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Propericiazine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Propericiazine—Rash—Mycophenolate mofetil—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Propericiazine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Propericiazine—Insomnia—Prednisone—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Propericiazine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Propericiazine—Constipation—Prednisone—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Propericiazine—Confusional state—Methotrexate—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Propericiazine—Infection—Methotrexate—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Propericiazine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Propericiazine—Body temperature increased—Prednisone—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Propericiazine—Hypotension—Methotrexate—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Propericiazine—Insomnia—Methotrexate—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Propericiazine—Dyspnoea—Methotrexate—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Propericiazine—Somnolence—Methotrexate—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Propericiazine—Hypersensitivity—Prednisone—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Propericiazine—Diarrhoea—Prednisone—systemic scleroderma	0.000976	0.000976	CcSEcCtD
Propericiazine—Body temperature increased—Methotrexate—systemic scleroderma	0.000943	0.000943	CcSEcCtD
Propericiazine—Vomiting—Prednisone—systemic scleroderma	0.000907	0.000907	CcSEcCtD
Propericiazine—Rash—Prednisone—systemic scleroderma	0.0009	0.0009	CcSEcCtD
Propericiazine—Dermatitis—Prednisone—systemic scleroderma	0.000899	0.000899	CcSEcCtD
Propericiazine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000879	0.000879	CcSEcCtD
Propericiazine—Nausea—Prednisone—systemic scleroderma	0.000848	0.000848	CcSEcCtD
Propericiazine—Diarrhoea—Methotrexate—systemic scleroderma	0.000816	0.000816	CcSEcCtD
Propericiazine—Vomiting—Methotrexate—systemic scleroderma	0.000758	0.000758	CcSEcCtD
Propericiazine—Rash—Methotrexate—systemic scleroderma	0.000752	0.000752	CcSEcCtD
Propericiazine—Dermatitis—Methotrexate—systemic scleroderma	0.000751	0.000751	CcSEcCtD
Propericiazine—Nausea—Methotrexate—systemic scleroderma	0.000708	0.000708	CcSEcCtD
